Polysorbates for Biopharmaceuticals - Unnecessarily Complex Mixture or Synergistic Blend?

Croda’s Market Application Specialist, James Humphrey, presented his work on polysorbates for biopharmaceuticals at this year's DDF summit in Berlin. He discussed the complexity, performance and components of polysorbates, as well as their interactions with model biopharmaceutical formulations.

Like Comment


Established in 1925, Croda is the name behind high performance ingredients and technologies in some of the world’s biggest and most successful brands: creating, making and selling speciality chemicals that are relied on by industries and consumers everywhere. They have a network of over 4,500 passionate and committed employees, working together as one global team across manufacturing sites and offices in 38 countries. Within the Health Care market, Croda offers high purity pharmaceutical excipients, highly performing vaccine adjuvants and in-house formulation expertise, making them the ideal solutions provider with whom to navigate drug and vaccine formulation challenges. Their product portfolio is proven to solubilise, stabilise and deliver the most challenging of active pharmaceutical ingredients, while high investment in GMP and multi-site EXCiPACT accreditation demonstrates confidence in both excipient quality and supply chain security.
0 Contributions
0 Following